Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.38
Delayed Data
As of Apr 26
 +0.08 / +2.42%
Today’s Change
2.85
Today|||52-Week Range
5.13
-4.52%
Year-to-Date
Meditor Group Ltd Buys Celldex Therapeutics, Sells VIVUS
Apr 24 / GuruFocus News - Paid Partner Content
What's in Store for Biogen (BIIB) this Earnings Season?
Apr 20 / Zacks.com - Paid Partner Content
What's in Store for GlaxoSmithKline (GSK) in Q1 Earnings?
Apr 21 / Zacks.com - Paid Partner Content
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?
Apr 20 / Zacks.com - Paid Partner Content
Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?
Apr 21 / Zacks.com - Paid Partner Content
Why Is Celldex (CLDX) Down 4.4% Since the Last Earnings Report?
Apr 19 / Zacks.com - Paid Partner Content